Drugs / Lactobacillus reuteri DSM 17938
Lactobacillus reuteri DSM 17938
Trials 8
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT04541771 | Oct → Dec 2020 | infectious disease with sepsis, necrotizing enterocolitis | Children's Hospital and Institute of Child Health, Multan | Unknown | No outcome recorded |
| Phase 2 | NCT01541046 | Nov 2011 → Jun 2014 | — | The Hospital for Sick Children | Completed | No outcome recorded |
| Phase 31 trial · 1 missed | ||||||
| Phase 3 | NCT02803827 | Jun 2016 → Jan 2019 | gastroenteritis | Hamilton Health Sciences Corporation | Completed | Missed primary |
| Phase 43 trials · 1 met primary | ||||||
| Phase 4 | NCT03117322 | Jun 2017 → Dec 2018 | cerebral palsy, constipation disorder | Andrea Garcia Contreras | Completed | No outcome recorded |
| Phase 4 | NCT02765217 | Jun 2017 → Jul 2020 | diarrheal disease | Eskisehir Osmangazi University | Completed | Met primary |
| Phase 4 | NCT02871908 | Dec 2016 → Mar 2018 | diarrheal disease | Medical University of Warsaw | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT06802042 | Jan → Dec 2025 overdue | constipation disorder | Peking Union Medical College Hospital | Recruiting | No outcome recorded |
| — | NCT02574065 | Mar 2016 → Apr 2017 | — | Shanghai Children's Hospital | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02734446 Comparator | Apr 2014 → Feb 2015 | asthma | University of Campania Luigi Vanvitelli | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactobacillus reuteri DSM 17938 | “Our research team found a probiotic strain, Lactobacillus reuteri DSM17938+, which has no significant difference in improving constipation symptoms in patients with...” NCT06802042 ↗8“The probiotic given will be Lactobacillus reuteri DSM 17938, 5x10e8 cfu/mL x 60 days, suspended in vegetable oil.” NCT02803827 ↗ “Lactobacillus reuteri DSM 17938 (108 CFU) + Vitamin D3 (400 IU) 5 drops/day for 3 months (Reuterin D3 drops)” NCT02734446 ↗ “Effects on crying time in colicky infants with the supplementation of Lactobacillus reuteri DSM 17938” NCT02574065 ↗ “Freeze-dried Lactobacillus reuteri DSM 17938 suspended in oil.” NCT01541046 ↗ |
| Known as | BioGaia | “Biogaia L. reuteri DSM 17938” NCT01541046 ↗ |
| Known as | L reuteri DSM 17938 | “they will additionally receive L. reuteri DSM 17938 at a dose 108 colony-forming units or an identically appearing placebo, orally, twice daily” PMID 28057659 ↗ Jan 2017 |
| Known as | L. reuteri | “CONCLUSIONS: In children hospitalised for acute gastroenteritis in Botswana, neither a test-and-treat algorithm targeting enteropathogens, nor a 60-day course of L. reuteri DSM...” PMID 35418412 ↗ Apr 2022 |
| Modality | Other / unclassified | “oral administration of the probiotic L. reuteri DSM 17938” NCT01541046 ↗ |
| Route | Oral | “oral administration of the probiotic L. reuteri DSM 17938” NCT01541046 ↗ |